NIH-funded research R01 grant

Glucagon Pump Therapy for PBH in People After Bariatric Surgery

Official title: Glucagon Pump Therapy for Post-Bariatric Hypoglycemia: Merging Physiology and Engineering

Funded at Joslin Diabetes Center · NIH-11369636 · Data updated 2026-11-12

A new approach uses a patch pump and smart control to deliver glucagon during meal-related lows in adults who had bariatric surgery and developed dangerous hypoglycemia.

More Hypoglycemia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJoslin Diabetes Center
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 20, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$709,250
NIH project number5R01DK137518-04
Project IDNIH-11369636 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with post-bariatric hypoglycemia who experience clinically significant lows despite current treatments.

Less likely to help

Patients with PBH who are intolerant to glucagon or have contraindications to pump therapy may not benefit.

What this research studies

If you’ve had bariatric surgery and suffer from severe low blood sugar, this project aims to help by using a closed-loop system that reads glucose levels and automatically delivers glucagon to prevent fainting or brain trouble. The study builds on earlier work that paired continuous glucose monitoring with a small pump and algorithm to give bursts of glucagon when lows are starting. Researchers will test the safety and practicality of this system in people with PBH, comparing it to standard care in a controlled setting. The goal is to make glucose management simpler and safer for patients who struggle with unpredictable lows.

Why it matters

Potential benefit: If successful, patients could experience fewer severe hypoglycemia events and more stable daily glucose control.

How similar studies have gone: Prior work showed that closed-loop glucagon delivery can be effective and safe in PBH, supporting further development.

Where this research is happening

  • Joslin Diabetes Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Patti, Mary E — Joslin Diabetes Center
  • Study coordinator: Patti, Mary E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.